Evolution of US military transfusion support for resuscitation of trauma and hemorrhagic shock;évolution de la réanimation transfusionnelle du blessé hémorragique grave au sein des forces militaires américaines

Transfusion Clinique et Biologique

Volumn 20, Issue 2, 2013, Pages 225-230

  Prat, N ^a,b   Pidcoke, H F ^a   Sailliol, A ^c   Cap, A P ^a  

^a US Army Institute of Surgical Research   (United States)

^b INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^c Centre de Transfusion Sanguine des Armees   (France)

Author keywords

1:1:1 component therapy; Acute coagulopathy of trauma; Damage control resuscitation; FFP:RBC; Freeze dried plasma; Fresh whole blood; Hemorrhagic shock; Joint Theater Trauma Registry; Platelet:RBC; Tranexamic acid

Indexed keywords

TRANEXAMIC ACID;

ANTICOAGULATION; AUTOPSY; BATTLE INJURY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; DEVICE THERAPY; DISEASE SEVERITY; HEMORRHAGIC SHOCK; HUMAN; MEDICAL DEVICE; MEDICAL PERSONNEL; MILITARY MEDICINE; PROFESSIONAL KNOWLEDGE; RESUSCITATION; SHORT SURVEY; THROMBOCYTE TRANSFUSION;

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; FORECASTING; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HOSPITALS, MILITARY; HUMANS; MEDICAL RECORDS; MILITARY MEDICINE; MOBILE HEALTH UNITS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RESUSCITATION; SHOCK, HEMORRHAGIC; TOURNIQUETS; TRANEXAMIC ACID; WAR; WOUNDS AND INJURIES;

EID: 84878115812     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2013.02.003     Document Type: Short Survey

References (80)

1. Scalea T.M. Hemostatic resuscitation for acute traumatic coagulopathy. Scand J Trauma Resusc Emerg Med 2011, 19:2.
2. Kragh J.F., et al. Historical review of emergency tourniquet use to stop bleeding. Am J Surg 2012, 203:242-252.
3. Blackbourne L.H., et al. Military medical revolution: prehospital combat casualty care. J Trauma Acute Care Surg 2012, 73:S372-S377.
4. Moore E.E. Thomas G. Orr Memorial Lecture. Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 1996, 172:405-410.
5. Neel, M.G.S., Medical support of the U.S. Army in Vietnam 1965-1970. , 1991. http://history.amedd.army.mil/booksdocs/vietnam/medicalsupport/default.html.
6. Moore F.A., McKinley B.A., Moore E.E. The next generation in shock resuscitation. Lancet 2004, 363:1988-1996.
7. McGonigal M.D., et al. Urban firearm deaths: a five-year perspective. J Trauma 1993, 35:532-536. [Discussion 536-7].
8. Kashuk J.L., et al. Major abdominal vascular trauma - a unified approach. J Trauma 1982, 22:672-679.
9. Burch J.M., Denton J.R., Noble R.D. Physiologic rationale for abbreviated laparotomy. Surg Clin North Am 1997, 77:779-782.
10. Ferrara A., et al. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 1990, 160:515-518.
11. Schreiber M.A. Damage control surgery. Crit Care Clin 2004, 20:101-118.
12. Rotondo M.F., et al. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993, 35:375-382. [Discussion 382-3].
13. Rotondo M.F., Zonies D.H. The damage control sequence and underlying logic. Surg Clin North Am 1997, 77:761-777.
14. Ivatury R.R. Supranormal trauma resuscitation and abdominal compartment syndrome. Arch Surg 2004, 139:225-226. [Author reply 226-7].
15. Ivatury R.R., Sugerman H.J. Abdominal compartment syndrome: a century later, isn't it time to pay attention?. Crit Care Med 2000, 28:2137-2138.
16. Ivatury R.R., Sugerman H.J., Peitzman A.B. Abdominal compartment syndrome: recognition and management. Adv Surg 2001, 35:251-269.
17. Ivatury R.R., et al. Intra-abdominal hypertension after life-threatening penetrating abdominal trauma: prophylaxis, incidence, and clinical relevance to gastric mucosal pH and abdominal compartment syndrome. J Trauma 1998, 44:1016-1021. [Discussion 1021-3].
18. Ivatury R.R., et al. Intra-abdominal hypertension and the abdominal compartment syndrome. Surg Clin North Am 1997, 77:783-800.
19. Saggi B.H., et al. Abdominal compartment syndrome. J Trauma 1998, 45:597-609.
20. Rodas E.B., et al. Hyperacute abdominal compartment syndrome: an unrecognized complication of massive intraoperative resuscitation for extra-abdominal injuries. Am Surg 2005, 71:977-981.
21. Schein M., et al. The abdominal compartment syndrome: the physiological and clinical consequences of elevated intra-abdominal pressure. J Am Coll Surg 1995, 180:745-753.
22. Schein M., Ivatury R. Intra-abdominal hypertension and the abdominal compartment syndrome. Br J Surg 1998, 85:1027-1028.
23. Hess J.R., Holcomb J.B., Hoyt D.B. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion 2006, 46:685-686.
24. Holcomb J.B., et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007, 62:307-310.
25. Blackbourne L.H., et al. Military medical revolution: deployed hospital and en route care. J Trauma Acute Care Surg 2012, 73:S378-S387.
26. Holcomb J.B., et al. Understanding combat casualty care statistics. J Trauma 2006, 60:397-401.
27. Eastridge B.J., et al. Impact of joint theater trauma system initiatives on battlefield injury outcomes. Am J Surg 2009, 198:852-857.
28. Eastridge B.J., et al. Death on the battlefield (2001-2011): implications for the future of combat casualty care. J Trauma Acute Care Surg 2012, 73:S431-S437.
29. Blackbourne L.H., et al. Military medical revolution: military trauma system. J Trauma Acute Care Surg 2012, 73:S388-S394.
30. Eastridge B.J., et al. Died of wounds on the battlefield: causation and implications for improving combat casualty care. J Trauma 2011, 71:S4-S8.
31. Holcomb J.B., et al. Causes of death in U.S. special operations forces in the global war on terrorism: 2001-2004. Ann Surg 2007, 245:986-991.
32. Holcomb J.B., et al. Increased platelet: RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011, 71:S318-S328.
33. Kragh J.F., et al. New tourniquet device concepts for battlefield hemorrhage control. US Army Med Dep J 2011, 38-48.
34. Kragh J.F., et al. The military emergency tourniquet program's lessons learned with devices and designs. Mil Med 2011, 176:1144-1152.
35. Kheirabadi B.S., et al. Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine. J Trauma 2009, 66:316-326. [Discussion 327-8].
36. Kheirabadi B.S., et al. Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine. J Trauma 2010, 68:269-278.
37. Kheirabadi B.S., et al. Clot-inducing minerals versus plasma protein dressing for topical treatment of external bleeding in the presence of coagulopathy. J Trauma 2010, 69:1062-1072. [Discussion 1072-3].
38. Kheirabadi B.S., et al. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma 2009, 67:450-459. [Discussion 459-60].
39. Kragh J.F., Baer D.G., Walters T.J. Extended (16-hour) tourniquet application after combat wounds: a case report and review of the current literature. J Orthop Trauma 2007, 21:274-278.
40. Kragh J.F., et al. Survival with emergency tourniquet use to stop bleeding in major limb trauma. Ann Surg 2009, 249:1-7.
41. Kragh J.F., et al. Battle casualty survival with emergency tourniquet use to stop limb bleeding. J Emerg Med 2011, 41:590-597.
42. Granville-Chapman J., Jacobs N., Midwinter M.J. Pre-hospital haemostatic dressings: a systematic review. Injury 2011, 42:447-459.
43. Sipos P., et al. Special wound healing methods used in ancient Egypt and the mythological background. World J Surg 2004, 28:211-216.
44. Spinella P.C., et al. Constant challenges and evolution of US military transfusion medicine and blood operations in combat. Transfusion 2012, 52:1146-1153.
45. Pidcoke H.F., et al. 10-year analysis of transfusion in operation Iraqi freedom and operation enduring freedom: increased plasma and platelet use correlates with improved survival. J Trauma 2012, 73:S445-S452.
46. Borgman M.A., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
47. Brasel K.J., et al. The association of blood component use ratios with the survival of massively transfused trauma patients with and without severe brain injury. J Trauma 2011, 71:S343-S352.
48. Perkins J.G., et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009, 66:S77-S84. [Discussion S84-5].
49. Stinger H.K., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 64:S79-S85. [Discussion S85].
50. Perkins J.G., et al. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion 2011, 51:242-252.
51. Spinella P.C., et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009, 66:S69-S76.
52. Palm K., et al. Evaluation of military trauma system practices related to damage-control resuscitation. J Trauma Acute Care Surg 2012, 73:S459-S464.
53. Pidcoke H.F., et al. Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion 2013, 53:137S-149S.
54. Spinella P.C., Holcomb J.B. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009, 23:231-240.
55. Spinella P.C., et al. Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications. Anesth Analg 2012, 115:751-758.
56. Nessen S.C., et al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion 2013, 53:107S-113S.
57. Cap A.P., et al. Timing and location of blood product transfusion and outcomes in massively transfused combat casualties. J Trauma Acute Care Surg 2012, 73:S89-S94.
58. Brohi K. Trauma induced coagulopathy. J R Army Med Corps 2009, 155:320-322.
59. Brohi K. Diagnosis and management of coagulopathy after major trauma. Br J Surg 2009, 96:963-964.
60. Brohi K., Cohen M.J., Davenport R.A. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007, 13:680-685.
61. Brohi K., et al. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
62. Cohen M.J., et al. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg 2012, 255:379-385.
63. Cohen M.J., West M. Acute traumatic coagulopathy: from endogenous acute coagulopathy to systemic acquired coagulopathy and back. J Trauma 2011, 70:S47-S49.
64. Frith D., Brohi K. The acute coagulopathy of trauma shock: clinical relevance. Surgeon 2010, 8:159-163.
65. Frith D., Brohi K. The pathophysiology of trauma-induced coagulopathy. Curr Opin Crit Care 2012, 18:631-636.
66. Frith D., Davenport R., Brohi K. Acute traumatic coagulopathy. Curr Opin Anaesthesiol 2012, 25:229-234.
67. Brohi K., et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Ann Surg 2007, 245:812-818.
68. Brohi K., et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008, 64:1211-1217. [Discussion 1217].
69. Martinowitz U., et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001, 51:431-438. [Discussion 438-9].
70. Morse B.C., et al. The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. Am Surg 2011, 77:1043-1049.
71. Koh Y.R., et al. Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas. Ann Lab Med 2012, 32:145-152.
72. Dutton R.P., et al. Recombinant activated factor VII safety in trauma patients: results from the CONTROL trial. J Trauma 2011, 71:12-19.
73. Shakur H., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376:23-32.
74. Morrison J.J., et al. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg 2012, 147:113-119.
75. http://www.usaisr.amedd.army.mil/clinical_practice_guidelines.html.
76. Spinella P.C. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med 2008, 36:S340-S345.
77. Kendrick, B.G.D.B., MC, USA, blood program in World War II. , 1964. http://history.amedd.army.mil/booksdocs/wwii/blood/default.htm.
78. Goodrich R.P., et al. Improving blood safety and patient outcomes with pathogen reduction technology. Transfus Apher Sci 2011, 45:229-238.
79. Gerhardt R.T., et al. Remote damage control resuscitation and the solstrand conference: defining the need, the language, and a way forward. Transfusion 2013, 53:9S-16S.
80. Pusateri A.E., et al. Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock 2013, 39:121-126.